The University of Chicago Header Logo

Connection

S. Murray Sherman to Proteinuria

This is a "connection" page, showing publications S. Murray Sherman has written about Proteinuria.
Connection Strength

0.490
  1. Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes. Endocrine. 2017 Apr; 56(1):121-128.
    View in: PubMed
    Score: 0.490
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.